Wilson Sonsini Goodrich & Rosati advised ChargePoint on the transaction. ChargePoint, a leading electric vehicle (EV) charging network, announced a partnership with Goldman Sachs Renewable Power...
ChargePoint’s Partnership with Goldman Sachs Renewable Power
ViFive’s $5.8 Million Funding Round
Wilson Sonsini Goodrich & Rosati advised ViFive on the financing. ViFive, an innovator in Vision AI technology, announced a pre-A funding of $5.8 million. The funding...
IGM Biosciences’ $230 Million Public Offering
Wilson Sonsini Goodrich & Rosati advised IGM on the transaction. IGM Biosciences, Inc. announced the pricing of its underwritten public offering of 8,695,653 shares of its...
Remote’s $300 Million Series C Financing Round
Wilson Sonsini advised Remote on the deal, while Latham & Watkins represented SoftBank Vision Fund 2. Remote, a leader in building, managing, and supporting global, distributed...
EQRx’s Collaboration with Insilico Medicine
Ropes & Gray advised EQRx in the deal while Wilson Sonsini Goodrich & Rosati represented InSilico. EQRx annlounced a strategic collaboration with Insilico Medicine to jointly...
LayerZero Labs’ $135 Million Series A Funding Round
Lowenstein represented LayerZero Labs Ltd. in the transaction while Orrick advised PayPal Ventures. LayerZero Labs Ltd., a provider of omnichain crypto networks, executed its $135 million...
HP’s $3.3 Billion Acquisition of Poly
Davis Polk & Wardwell, Ropes & Gray and Skadden, Arps, Slate, Meagher & Flom advised HP on the deal. Wilson Sonsini Goodrich & Rosati represented Poly....
Apexigen’s Business Combination Agreement with Brookline Capital Acquisition Corp.
Wilson Sonsini advised Apexigen on the deal. Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology,...
House Rx’s $30 Million Financing
Wilson Sonsini Goodrich & Rosati advised House Rx on the deal. House Rx, a health technology platform focused on improving affordability and patient access to specialty...
Affini-T Therapeutics’ $175 Million Financing
Latham & Watkins and Wilson Sonsini represented Affini-T Therapeutics, Inc. in the transaction. Affini-T Therapeutics, Inc., a biotechnology company unlocking the power of T cells against oncogenic...
Block Tackle’s $5 Million Seed Round
Wilson Sonsini advised Block Tackle on the deal. Block Tackle, a new game studio founded by veterans from EA and Kabam, who will develop immersive games...
NuVasive v. Alphatec
Wilson Sonsini advised NuVasive on the deal. After a two-week jury trial NuVasive obtained a victory against spine surgery competitor Alphatec. In the early 2000s, NuVasive pioneered the eXtreme...